117 related articles for article (PubMed ID: 21830727)
1. [Studies with telaprevir].
MMW Fortschr Med; 2011 Jul; 153(29-31):15. PubMed ID: 21830727
[No Abstract] [Full Text] [Related]
2. Study Results Support Telaprevir-Based Therapy for HCV.
AIDS Patient Care STDS; 2010 Nov; 24(11):746. PubMed ID: 21108519
[No Abstract] [Full Text] [Related]
3. Phase 3 study results released for telaprevir and HCV.
AIDS Patient Care STDS; 2010 Oct; 24(10):685-6. PubMed ID: 20945535
[No Abstract] [Full Text] [Related]
4. [Studies with boceprevir].
MMW Fortschr Med; 2011 Jul; 153(29-31):16. PubMed ID: 21830728
[No Abstract] [Full Text] [Related]
5. [Telaprevir: new possibilities for antiviral treatment in patients with chronic hepatitis C].
Nikitin IG; Gogova LM; Baikova IE; Kislyakov VA; Volynkina VM
Ter Arkh; 2012; 84(11):75-80. PubMed ID: 23252254
[TBL] [Abstract][Full Text] [Related]
6. [A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].
Manns M
MMW Fortschr Med; 2011 Jul; 153(29-31):17. PubMed ID: 21830729
[No Abstract] [Full Text] [Related]
7. Telaprevir-induced DRESS.
Kesar V; Kesar V; Khaitova V; Motamed D; Schiano T
J Drugs Dermatol; 2014 Feb; 13(2):199-200. PubMed ID: 24509972
[TBL] [Abstract][Full Text] [Related]
8. Infectious diseases. First specific drugs raise hopes for hepatitis C.
Enserink M
Science; 2011 Apr; 332(6026):159-60. PubMed ID: 21474720
[No Abstract] [Full Text] [Related]
9. Telaprevir: hope on the horizon, getting closer.
Weisberg IS; Jacobson IM
Clin Liver Dis; 2009 Aug; 13(3):441-52. PubMed ID: 19628160
[TBL] [Abstract][Full Text] [Related]
10. Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions.
Seden K; Back D
Curr Opin HIV AIDS; 2011 Nov; 6(6):514-26. PubMed ID: 22001895
[TBL] [Abstract][Full Text] [Related]
11. Telaprevir for chronic HCV infection.
van der Meer AJ; de Knegt RJ
N Engl J Med; 2009 Jul; 361(5):533-4; author reply 534-5. PubMed ID: 19641215
[No Abstract] [Full Text] [Related]
12. Hepatitis C genotype 1b and 4 cured after telaprevir-based therapy.
Pérez-Parente D; Suárez-Ordóñez S; Suárez-Santamaría M; Morano-Amado LE
Rev Esp Enferm Dig; 2015 Apr; 107(4):251. PubMed ID: 25824935
[No Abstract] [Full Text] [Related]
13. [New times for the treatment of chronic hepatitis C].
Gerstoft J; Fomsgaard A
Ugeskr Laeger; 2012 Mar; 174(12):795. PubMed ID: 22433552
[No Abstract] [Full Text] [Related]
14. [Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications].
Lange CM; Sarrazin C; Zeuzem S
Pharm Unserer Zeit; 2011 Jan; 40(1):60-7. PubMed ID: 21194084
[No Abstract] [Full Text] [Related]
15. Targeted therapies for hepatitis C reach the clinic.
Erdmann J
Chem Biol; 2012 Apr; 19(4):433-4. PubMed ID: 22520745
[No Abstract] [Full Text] [Related]
16. Telaprevir: a new hope in the treatment of chronic hepatitis C?
Fowell AJ; Nash KL
Adv Ther; 2010 Aug; 27(8):512-22. PubMed ID: 20652658
[TBL] [Abstract][Full Text] [Related]
17. Excitement grows for potential revolution in hepatitis C virus treatment.
Opar A
Nat Rev Drug Discov; 2010 Jul; 9(7):501-3. PubMed ID: 20592732
[No Abstract] [Full Text] [Related]
18. [Efficacy of and indications for IFN retreatment of patients with chronic hepatitis C].
Iyoda K; Kato M
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):502-5. PubMed ID: 15359850
[No Abstract] [Full Text] [Related]
19. [Treatment of patients with chronic hepatitis C who have not been previously treated].
Marcellin P; Boyer N
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B194-201. PubMed ID: 12180288
[No Abstract] [Full Text] [Related]
20. New HCV drugs trigger race for more tolerable therapies.
Williams SC
Nat Med; 2011 Dec; 17(12):1526. PubMed ID: 22146431
[No Abstract] [Full Text] [Related]
[Next] [New Search]
